SEARCH

SEARCH BY CITATION

References

  • Agarwal, A., Mauer, S. M., Matas, A. J. & Nath, K. A. (1995) Recurrent hemolytic uremic syndrome in an adult renal allograft recipient: current concepts and management. J Am Soc Nephrol 6, 11601169.
  • Artz, M. A., Steenbergen, E. J., Hoitsma, A. J., Monnens, L. A. & Wetzels, J. F. (2003) Renal transplantation in patients with hemolytic uremic syndrome: high rate of recurrence and increased incidence of acute rejections. Transplantation 76, 821826.
  • Bettinaglio, P., Galbusera, A., Caprioli, J., Orisio, S., Perna, A., Arnoldi, F., Bucchioni, S. & Noris, M. (2002) Single Strand Conformation Polymorphism (SSCP) as a quick and reliable method to genotype M235T polymorphism of angiotensinogen gene. Clin Biochem 35, 363368.
  • Caprioli, J., Bettinaglio, P., Zipfel, P. F., Amadei, B., Daina, E., Gamba, S., Skerka, C., Marziliano, N., Remuzzi, G. & Noris, M. (2001) The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. J Am Soc Nephrol 12, 297307.
  • Caprioli, J., Noris, M., Brioschi, S., Pianetti, G., Castelletti, F., Bettinaglio, P., Mele, C., Bresin, E., Cassis, L., Gamba, S., Porrati, F., Bucchioni, S., Monteferrante, G., Fang, C. J., Liszewski, M. K., Kavanagh, D., Atkinson, J. P. & Remuzzi, G. (2006) Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 108, 12671279.
  • Conlon, P. J., Brennan, D. C., Pfaf, W. W., Finn, W. F., Gehr, T., Bollinger, R. R. & Smith, S. R. (1996) Renal transplantation in adults with thrombotic thrombocytopenic purpura/haemolytic-uraemic syndrome. Nephrol Dial Transplant 11, 18101814.
  • Delvaeye, M., Noris, M., De Vriese, A., Esmon, C. T., Esmon, N. L., Ferrell, G., Del-Favero, J., Plaisance, S., Claes, B., Lambrechts, D., Zoja, C., Remuzzi, G. & Conway, E. M. (2009) Thrombomodulin mutations in atypical hemolytic-uremic syndrome. N Engl J Med 361, 345357.
  • Esparza-Gordillo, J., Goicoechea De Jorge, E., Buil, A., Carreras Berges, L., Lopez-Trascasa, M., Sanchez-Corral, P. & Rodriguez De Cordoba, S. (2005) Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32. Hum Mol Genet 14, 703712.
  • Fang, C. J., Richards, A., Liszewski, M. K., Kavanagh, D. & Atkinson, J. P. (2008) Advances in understanding of pathogenesis of aHUS and HELLP. Br J Haematol 143, 336348.
  • Flicek, P., Aken, B.L., Beal, K., Ballester, B., Caccamo, M., Chen, Y., Clarke, L., Coates, G., Cunningham, F., Cutts, T., Down, T., Dyer, S. C., Eyre, T., Fitzgerald, S., Fernandez-Banet, J., Gräf, S., Haider, S., Hammond, M., Holland, R., Howe, K.L., Howe, K., Johnson, N., Jenkinson, A., Kähäri, A., Keefe, D., Kokocinski, F., Kulesha, E., Lawson, D., Longden, I., Megy, K., Meidl, P., Overduin, B., Parker, A., Pritchard, B., Prlic, A., Rice, S., Rios, D., Schuster, M., Sealy, I., Slater, G., Smedley, D., Spudich, G., Trevanion, S., Vilella, A. J., Vogel, J., White, S., Wood, M., Birney, E., Cox, T., Curwen, V., Durbin, R., Fernandez-Suarez, X. M., Herrero, J., Hubbard, T. J., Kasprzyk, A., Proctor, G., Smith, J., Ureta-Vidal, A. & Searle, S. (2008) ENSEMBL 2008. Nucleic Acids Res 36, D707714.
  • Fremeaux-Bacchi, V., Dragon-Durey, M. A., Blouin, J., Vigneau, C., Kuypers, D., Boudailliez, B., Loirat, C., Rondeau, E. & Fridman, W. H. (2004) Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome. J Med Genet 41, e84.
  • Fremeaux-Bacchi, V., Kemp, E. J., Goodship, J. A., Dragon-Durey, M. A., Strain, L., Loirat, C., Deng, H. W. & Goodship, T. H. (2005) The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts. J Med Genet 42, 852856.
  • Fremeaux-Bacchi, V., Miller, E. C., Liszewski, M. K., Strain L., Blouin, J., Brown, A. L., Moghal, N., Kaplan, B. S., Weiss, R. A., Lhotta, K., Kapur, G., Mattoo, T., Nivet, H., Wong, W., Gie, S., Hurault De Ligny, B., Fischbach, M., Gupta, R., Hauhart, R., Meunier, V., Loirat, C., Dragon-Durey, M. A., Fridman, W. H., Janssen, B. J., Goodship, T. H. & Atkinson, J. P. (2008) Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood 112, 49484952.
  • Fremeaux-Bacchi, V., Moulton, E. A., Kavanagh, D., Dragon-Durey, M. A., Blouin, J., Caudy, A., Arzouk, N., Cleper, R., Francois, M., Guest, G., Pourrat, J., Seligman, R., Fridman, W. H., Loirat, C. & Atkinson, J. P. (2006) Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. J Am Soc Nephrol 17, 20172025.
  • George, J. N. (2006) Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 354, 19271935.
  • Goicoechea De Jorge, E., Harris, C. L., Esparza-Gordillo, J., Carreras, L., Arranz, E. A., Garrido, C. A., Lopez-Trascasa, M., Sanchez-Corral, P., Morgan, B. P. & Rodriguez De Cordoba, S. (2007) Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proc Natl Acad Sci U S A 104, 240245.
  • Heinen, S., Sanchez-Corral, P., Jackson, M. S., Strain, L., Goodship, J. A., Kemp, E. J., Skerka, C., Jokiranta, T. S., Meyers, K., Wagner, E., Robitaille, P., Esparza-Gordillo, J., Rodriguez De Cordoba, S., Zipfel, P. F. & Goodship, T. H. (2006) De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome. Hum Mutat 27, 292293.
  • Kaplan, B. S., Meyers, K. E. & Schulman, S. L. (1998) The pathogenesis and treatment of hemolytic uremic syndrome. J Am Soc Nephrol 9, 11261133.
  • Kavanagh, D., Kemp, E. J., Mayland, E., Winney, R. J., Duffield, J. S., Warwick, G., Richards, A., Ward, R., Goodship, J. A. & Goodship, T. H. (2005) Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome. J Am Soc Nephrol 16, 21502155.
  • Kavanagh, D., Richards, A. & Atkinson, J. (2008) Complement regulatory genes and hemolytic uremic syndromes. Annu Rev Med 59, 293309.
  • Lahlou, A., Lang, P., Charpentier, B., Barrou, B., Glotz, D., Baron, C., Hiesse, C., Kreis, H., Legendre, C., Bedrossian, J., Mougenot, B., Sraer, J. D. & Rondeau, E. (2000) Hemolytic uremic syndrome. Recurrence after renal transplantation. Groupe Cooperatif de l'Ile-de-France (GCIF). Medicine (Baltimore) 79, 90102.
  • Miller, R. B., Burke, B. A., Schmidt, W. J., Gillingham, K. J., Matas, A. J., Mauer, M. & Kashtan, C. E. (1997) Recurrence of haemolytic-uraemic syndrome in renal transplants: a single-centre report. Nephrol Dial Transplant 12, 14251430.
  • Neumann, H. P., Salzmann, M., Bohnert-Iwan, B., Mannuelian, T., Skerka, C., Lenk, D., Bender, B. U., Cybulla, M., Riegler, P., Konigsrainer, A., Neyer, U., Bock, A., Widmer, U., Male, D. A., Franke, G. & Zipfel, P. F. (2003) Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries. J Med Genet 40, 676681.
  • Ng, P. C. & Henikoff, S. (2006) Predicting the effects of amino acid substitutions on protein function. Annu Rev Genomics Hum Genet 7, 6180.
  • Noris, M., Brioschi, S., Caprioli, J., Todeschini, M., Bresin, E., Porrati, F., Gamba, S. & Remuzzi G. (2003) Familial haemolytic uraemic syndrome and an MCP mutation. Lancet 362, 15421547.
  • Rey-Campos, J., Rubinstein, P. & Rodriguez De Cordoba, S. (1988) A physical map of the human regulator of complement activation gene cluster linking the complement genes CR1, CR2, DAF, and C4BP. J Exp Med 167, 664669.
  • Richards, A., Buddles, M. R., Donne, R. L., Kaplan, B. S., Kirk, E., Venning, M. C., Tielemans, C. L., Goodship, J. A. & Goodship, T. H. (2001) Factor H mutations in hemolytic uremic syndrome cluster in exons 18–20, a domain important for host cell recognition. Am J Hum Genet 68, 485490.
  • Richards, A., Kemp, E. J., Liszewski, M. K., Goodship, J. A., Lampe, A. K., Decorte, R., Muslumanoglu, M. H., Kavucku, S., Filler, G., Pirson, Y., Wen, L. S., Atkinson, J. P. & Goodship, T. H. (2003) Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc Natl Acad Sci U S A 100, 1296612971.
  • Rock, G. A., Shumak, K. H., Buskard, N. A., Blanchette, V. S., Kelton, J. G., Nair, R. C. & Spasoff, R. A. (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 325, 393397.
  • Sanchez-Corral, P., Perez-Caballero, D., Huarte, O., Simckes, A. M., Goicoechea, E., Lopez-Trascasa, M. & De Cordoba, S. R. (2002) Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome. Am J Hum Genet 71, 12851295.
  • Saunders, R. E., Goodship, T. H., Zipfel, P. F. & Perkins, S. J. (2006) An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations. Hum Mutat 27, 2130.
  • Vyse, T. J., Morley, B. J., Bartok, I., Theodoridis, E. L., Davies, K. A., Webster, A. D. & Walport, M. J. (1996) The molecular basis of hereditary complement factor I deficiency. J Clin Invest 97, 925933.
  • Warwicker, P., Goodship, T. H., Donne, R. L., Pirson, Y., Nicholls, A., Ward, R. M., Turnpenny, P. & Goodship, J. A. (1998) Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int 53, 836844.
  • Xiao, W. & Oefner, P. J. (2001) Denaturing high-performance liquid chromatography: A review. Hum Mutat 17, 439474.